Stocks and Investing Stocks and Investing
Thu, August 15, 2024

Brian Abrahams Reiterated (SRPT) at Buy and Held Target at $181 on, Aug 15th, 2024


Published on 2024-10-28 13:40:26 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Reiterated "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $181 on, Aug 15th, 2024.

Brian has made no other calls on SRPT in the last 4 months.



There are 14 other peers that have a rating on SRPT. Out of the 14 peers that are also analyzing SRPT, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Hoang of "Citigroup" Maintained at Hold with Decreased Target to $160 on, Thursday, August 8th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $152 on, Thursday, August 8th, 2024


These are the ratings of the 12 analyists that currently disagree with Brian


  • Gavin Clark-Gartner of "Evercore ISI Group" Upgraded from Hold to Buy and Decreased Target to $179 on, Thursday, August 8th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $203 on, Thursday, August 8th, 2024
  • Biren Amin of "Piper Sandler" Maintained at Buy with Decreased Target to $200 on, Thursday, August 8th, 2024
  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $235 on, Thursday, June 27th, 2024
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
  • Mani Foroohar of "Leerink Partners" Maintained at Buy with Increased Target to $230 on, Monday, June 24th, 2024
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $213 on, Friday, June 21st, 2024
  • Brian Skorney of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, June 21st, 2024
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $179 on, Friday, May 17th, 2024
  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024
Contributing Sources